Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#ANDA077831 ×

Regulatory Updates

Aug 30, 2026•1 min read

FDA Approves CILOSTAZOL Tablets (ANDA077831)

FDA has approved Chartwell Rx's ANDA077831 for oral CILOSTAZOL tablets in 50 mg and 100 mg strengths, with labeling updates approved in 2016.